IRIS
FRONTONI, SIMONA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 28.335
EU - Europa 1.972
AS - Asia 852
Continente sconosciuto - Info sul continente non disponibili 11
SA - Sud America 10
AF - Africa 6
OC - Oceania 6
Totale 31.192
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.323
SG - Singapore 407
UA - Ucraina 402
DE - Germania 349
IE - Irlanda 299
CN - Cina 283
IT - Italia 205
SE - Svezia 183
GB - Regno Unito 133
FR - Francia 103
RU - Federazione Russa 87
FI - Finlandia 83
KR - Corea 79
PL - Polonia 61
BE - Belgio 16
VN - Vietnam 16
CZ - Repubblica Ceca 14
HK - Hong Kong 13
JP - Giappone 13
RO - Romania 13
EU - Europa 10
CA - Canada 9
IN - India 9
BR - Brasile 7
KG - Kirghizistan 7
TR - Turchia 6
AU - Australia 5
UZ - Uzbekistan 5
NL - Olanda 4
CH - Svizzera 3
CL - Cile 3
DK - Danimarca 3
EG - Egitto 3
ES - Italia 3
IL - Israele 3
IR - Iran 3
GR - Grecia 2
HR - Croazia 2
HU - Ungheria 2
MD - Moldavia 2
MX - Messico 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
BD - Bangladesh 1
DM - Dominica 1
IQ - Iraq 1
KE - Kenya 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MA - Marocco 1
MK - Macedonia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
ZW - Zimbabwe 1
Totale 31.192
Salva come PNG Salva come JPEG
Città #
Woodbridge 8.253
Wilmington 7.718
Houston 6.638
Fairfield 992
Ann Arbor 698
Chandler 636
Ashburn 489
Seattle 371
Jacksonville 348
Singapore 337
Cambridge 318
Dublin 271
Medford 210
Dearborn 206
Beijing 131
New York 102
Lawrence 95
Santa Clara 68
Rome 67
Kraków 61
Menlo Park 39
Mülheim 39
Boardman 33
San Diego 33
Falls Church 28
Moscow 28
Buffalo 25
Palo Alto 25
Zhengzhou 22
Milan 21
Nanjing 20
Redwood City 20
San Mateo 19
London 18
Mountain View 18
Norwalk 18
Brussels 16
Dong Ket 16
Brno 14
Kunming 13
Verona 13
Chengdu 12
Guangzhou 12
Hong Kong 12
Nürnberg 12
Helsinki 11
Los Angeles 11
Munich 11
Indiana 10
Phoenix 10
University Park 10
Hefei 9
Shanghai 9
Auburn Hills 8
Creede 7
Saint Petersburg 7
Seoul 7
Detroit 6
Hangzhou 6
Nanchang 6
Nuremberg 6
Toronto 6
San Francisco 5
São Paulo 5
Tokyo 5
Baotou 4
Buguggiate 4
Changsha 4
Bengaluru 3
Chicago 3
Clearwater 3
Ebertsheim 3
Gravina di Catania 3
Hebei 3
Istanbul 3
Jinan 3
Lipari 3
Passirano 3
Redmond 3
Shenyang 3
Stony Brook 3
Venice 3
Alberobello 2
Aldeno 2
Alonsótegui 2
Arezzo 2
Berlin 2
Brugnera 2
Budapest 2
Cairo 2
Capaccio 2
Chisinau 2
Eiken 2
Engelhard 2
Florence 2
Foggia 2
Fremont 2
Hamburg 2
Hounslow 2
Jiaxing 2
Totale 28.780
Salva come PNG Salva come JPEG
Nome #
Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals 502
Highlights from "Italian Standards of care for Diabetes Mellitus 2009-2010". 444
Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management 435
Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments 431
The social burden of hypoglycemia in the elderly 431
Relationship between autonomic neuropathy, 24-h blood pressure profile, and nephropathy in normotensive IDDM patients 428
Impact of glycemic and blood pressure variability on surrogate measures of cardiovascular outcomes in type 2 diabetic patients 427
Continuous subcutaneous insulin infusion (CSII) in inpatient setting: unmet needs and the proposal of a CSII unit 423
Decreased insulin clearance in individuals with elevated 1-h post-load plasma glucose levels 422
Preliminary evidence that obese patients with obstructive sleep apnea/hypopnea syndrome are refractory to the acute beneficial metabolic effects of a very low calorie diet 421
Assessment of sympathetic innervation of the heart in diabetes mellitus using 123I-MIBG 419
Differences in insulin clearance between metabolically healthy and unhealthy obese subjects 418
Efficacy of antihypertensive treatment with indapamide in patients with noninsulin-dependent diabetes and persistent microalbuminuria 416
Acute caloric restriction improves glomerular filtration rate in patients with morbid obesity and type 2 diabetes 415
Increased left ventricular mass in normotensive diabetic patients with autonomic neuropathy 414
A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects 409
Early autonomic dysfunction in glucose-tolerant but insulin-resistant offspring of type 2 diabetic patients 408
Regression of microalbuminuria in type II diabetic,hypertensive patients after long-term indapamide treatment 408
Relationship between autonomic dysfunction, insulin resistance and hypertension, in diabetes 402
Comment on: Inzucchi et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364-1379. 400
Retinal neurodegeneration in patients with type 1 diabetes mellitus: the role of glycemic variability 397
Intravenous dexamethasone and subsequent ACTH test in comparison with dexamethasone oral test in the diagnosis of Cushing's syndrome: a report of 20 cases 394
C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance 392
Position Statement on the management of continuous subcutaneous insulin infusion (CSII): The Italian Lazio experience 389
Insulin clearance is associated with carotid artery intima-media thickness 384
Carbohydrate metabolism in hypertension: influence of treatment 384
Polymorphisms of the insulin receptor subtrate-2 in patients with type 2 diabetes 382
Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals 381
Insulin sensitivity, and β-cell function in relation to hemoglobin A1C 380
Effects of beta-adrenergic blockade on insulin-mediated glucose disposal in hypertensive and normotensive rats 376
A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects 376
Impact of glycemic variability on cardiovascular outcomes beyond glycated hemoglobin. Evidence and clinical perspectives. 375
Hyperinsulinaemia in offspring of Type 2 diabetic patients: impaired response of carbohydrate metabolism, but preserved cardiovascular response 374
Methods of investigation for cardiac autonomic dysfunction in human research studies 373
The -866A/A genotype in the promoter of the human uncoupling protein 2 gene is associated with insulin resistance and increased risk of type 2 diabetes 372
The Arg972 variant in insulin receptor substrate-1 is associated with an atherogenic profile in offspring of type 2 diabetic patients 371
Guidelines for the eligibility to sports activities and the monitoring of athletes with endocrine diseases [Linee Guida per la concessione dell'idoneità all'attività sportiva ed il monitoraggio degli atleti affetti da malattie del sistema endocrino] 370
High GADA titer increases the risk of insulin requirement in LADA patients: A 7-year follow-up (NIRAD study 7) 370
Evaluation of guidelines on diabetes medication. 368
Acute hyperglycemia reduces cerebrovascular reactivity: The role of glycemic variability 367
SYMPTOMATIC TREATMENT OF AUTONOMIC NEUROPATHY IN DIABETIC SUBJECTS 366
Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects: the GISIR database 365
Deep capillary plexus impairment in patients with type 1 diabetes mellitus with no signs of diabetic retinopathy revealed using optical coherence tomography angiography 361
The DAWN Youth WebTalk Study: methods, findings, and implications. 359
Cerebral hemodynamics and systemic endothelial function are already impaired in well-controlled type 2 diabetic patients, with short-term disease 359
Comment on: Kromhout et al. n-3 fatty acids, ventricular arrhythmia-related events, and fatal myocardial infarction in postmyocardial infarction patients with diabetes. 356
Single retinal layer evaluation in patients with type 1 diabetes with no or early signs of diabetic retinopathy: The first hint of neurovascular crosstalk damage between neurons and capillaries? 356
A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects 354
C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance 352
Glucose variability: An emerging target for the treatment of diabetes mellitus 352
Gastrointestinal autonomic neuropathy, erectile-, bladder- and sudomotor dysfunction in patients with diabetes mellitus: clinical impact, assessment, diagnosis, and management. 351
The need for identifying standardized indices for measuring glucose variability. 350
Continuous Subcutaneous Insulin Infusion (CSII) in Inpatient Setting: Unmet Needs and the Proposal of a CSII Unit. 349
A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects 348
Bariatric surgery or medical therapy for obesity 348
The ideal blood pressure target to prevent cardiovascular disease in type 2 diabetes: A neutral viewpoint 348
Metabolic syndrome in subjects at high risk for type 2 diabetes: The genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study. 343
Polymorphisms of the insulin receptor substrate-2 in patients with type 2 diabetes 333
Guidelines for the eligibility to sports activities and the monitoring of athletes with endocrine diseases 333
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial 329
Twenty-four hours blood pressure and heart rate profiles in diabetics with and without autonomic neuropathy 329
Polymorphisms of the insulin receptor substrate-2 in patients with type 2 diabetes 326
Cardiovascular Autonomic Neuropathy and Glucose Variability in Patients With Type 1 Diabetes: Is There an Association? 324
The Arg972 variant in insulin receptor substrate-1 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes 322
Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy nonobese women and obese insulin-resistant women 321
Effect of the GSTM1 gene deletion on glycemic variability, sympatho-vagal balance and arterial stiffness in patients with metabolic syndrome, but without diabetes 321
QTc and autonomic neuropathy in diabetes: effects of acute hyperglycaemia and n-3 PUFA 319
Correspondence between the international diabetes federation criteria for metabolic syndrome and insulin resistance in a cohort of Italian nondiabetic caucasians: The GISIR database [4] 314
Pathogenetic mechanisms and cardiovascular risk: differences between HbA(1c) and oral glucose tolerance test for the diagnosis of glucose tolerance. 314
Mancato effetto dell’iperinsulinemia esogena sui valori della pressione arteriosa e sull’attività simpatica nei soggetti con diabete di tipo 1 e neuropatia autonomica 307
Carotid artery intima-media thickness is associated with insulin-mediated glucose disposal in nondiabetic normotensive offspring of type 2 diabetic patients 303
Early microvascular retinal changes in optical coherence tomography angiography in patients with type 1 diabetes mellitus 296
Effects of insulin on cholesterol synthesis in type II diabetes patients 288
Neuroretinal dysfunction is associated with early peripheral motor unit loss in type 1 diabetes 284
Insulin sensitivity, β-cell function, and incretin effect in individuals with elevated 1-hour postload plasma glucose levels 282
Very-low-calorie diet: a quick therapeutic tool to improve β cell function in morbidly obese patients with type 2 diabetes 277
La terapia insulinica aumenta il rischio cardiovascolare? 275
Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in a Real-Life Setting: A 24-Month, Multicenter, Non-interventional, Retrospective Study. 275
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial 271
Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion 254
Flavonoids and insulin-resistance: from molecular evidences to clinical trials 244
Rapid and easy assessment of insulin resistance contributes to early detection of polycystic ovary syndrome 233
Ten years of experience with DPP-4 inhibitors for the treatment of type 2 diabetes mellitus 223
Activation of retinal Müller cells in response to glucose variability 219
Neuroretinal Dysfunction Is Associated with Early Peripheral Motor Unit Loss in Type 1 Diabetes Mellitus 216
Association between Early Neuroretinal Dysfunction and Peripheral Motor Unit Loss in Patients with Type 1 Diabetes Mellitus 210
Predictors of treatment response to liraglutide in type 2 diabetes in a real-world setting 209
Early alterations of corneal subbasal plexus in uncomplicated type 1 diabetes patients 152
Urban diabetes: the case of the metropolitan area of Rome 146
The use of real time continuous glucose monitoring or flash glucose monitoring in the management of diabetes: A consensus view of Italian diabetes experts using the Delphi method 99
Urban diabetes: the case of the metropolitan area of Rome 57
Autonomic Nervous System in Obesity and Insulin-Resistance-The Complex Interplay between Leptin and Central Nervous System 51
Microvascular impairment as a biomarker of diabetic retinopathy progression in the long-term follow up in type 1 diabetes 50
Glycemic Status Assessment by the Latest Glucose Monitoring Technologies 48
Correction: Advice of General Practitioner, of Surgeon, of Endocrinologist, and Self-Determination: the Italian Road to Bariatric Surgery 38
Neuropathic damage in the diabetic eye: clinical implications 35
Outer retina dysfunction and choriocapillaris impairment in type 1 diabetes 31
The evaluation of tactile dysfunction in the hand in type 1 diabetes: a novel method based on haptics 29
MG53 marks poor beta cell performance and predicts onset of type 2 diabetes in subjects with different degrees of glucose tolerance 29
Metformin Benefits: Another Example for Alternative Energy Substrate Mechanism? 26
Totale 31.407
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.460
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.460
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207.029 0 0 580 770 763 891 818 756 751 674 478 548
2020/20214.873 522 610 534 596 487 503 603 486 136 113 191 92
2021/20221.072 41 112 77 52 52 112 49 56 49 100 57 315
2022/20231.523 148 118 78 201 171 317 129 89 158 3 69 42
2023/2024413 43 13 31 12 43 125 30 27 6 11 5 67
2024/2025662 115 537 10 0 0 0 0 0 0 0 0 0
Totale 31.431